Table 3.
DMPK Profiling of Early Analogues
![]() | ||||||||
---|---|---|---|---|---|---|---|---|
no. | cLogPa | LLEb | mGlu3 IC50 (nM) | fold vs mGlu5 | rat plasma Fuc | CLplasma (mL/min/kg)d | VSS (L/kg)d | |
24 | 3.96 | 2.38 | 462 | 0.20 | 0.060 | 95 | 40 | 3.5 |
38 | 4.24 | 1.70 | 1160 | >25 | 0.005 | 32 | 82 | 2.2 |
47 | 3.06 | 3.21 | 539 | >18 | 0.135 | 88 | 82 | 6.6 |
48 | 3.57 | 2.65 | 605 | 4.8 | 0.034 | 141 | 29 | 5.2 |
Calculated using Dotmatics Elemental (www.dotmatics.com/products/elemental/).
LLE (ligand-lipophilicity efficiency) = pIC50 – cLogP.
Fu = fraction unbound.
Rat IV PK results (n = 2); dose = 0.2 mg/kg; solution in 9% EtOH, 37% PEG 400, 54% DMSO (2 mg/mL).